TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PALI

Palisade Bio Inc

Healthcare · Biotechnology

1.50$ +2.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PALI
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -0.9% -2.3% -14.3% -35.8% -22.6% -97.9% -33.3% +50.0% +33.3% -25.0% +0.0%
– -31.7% +16.7% -48.6% -38.4% +205.0% -39.4% -6.1% -45.4% -39.5% +4.5% +506.6%
– – – – – +108.1% +6.4% +381.7% – – – –
– -117.6% – -242.5% – – +1,047.0% -299.1% – -68.0% +247.8% +17.8%
– -56.2% -33.9% -41.6% -98.2% +250.1% +0.0% -100.0% – -60.0% -100.0% –
– – -67.5% -104.0% – -21.5% -100.2% +800.0% -81.5% -60.0% – –
– – – – – – – – – – – –
– – – -68.9% -79.1% +258.5% +124.3% -100.7% – – -35.3% +72.7%
– – – – – -116.2% – -109.3% +331.7% -50.5% +9.0% -24.9%
– -83.1% +510.7% -79.0% -63.6% +263.2% -71.3% +1,202.1% -38.0% -26.7% -14.3% +1,303.0%
– – – -181.3% – – – – -80.7% -97.4% -5,428.6% –
– – – – – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?